NLRP3 and Parkinson disease: Furthermore, recent studies have demonstrated that inhibiting the assembly of the NLRP3 inflammasome in both familial and sporadic PD models leads to a reduction in dopaminergic neurodegeneration (Panicker et al., 2022).